MedPath

Effect of phosphate binder on serum level of FGF23: A comparison between ferric citrate hydrate and lanthanum carbonate.

Not Applicable
Conditions
chronic kidney disease
Registration Number
JPRN-UMIN000019669
Lead Sponsor
Hyogo College of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with iron excess

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The changes of serum FGF23 levels after 1 and 3 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath